CHEN Weiyun, DAI Yi, QIAN Min, LIANG Jinqian. Perioperative Management of SEPN1-Related Myopathy Accompanying Scoliosis: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0428
Citation: CHEN Weiyun, DAI Yi, QIAN Min, LIANG Jinqian. Perioperative Management of SEPN1-Related Myopathy Accompanying Scoliosis: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0428

Perioperative Management of SEPN1-Related Myopathy Accompanying Scoliosis: A Case Report

Funds: 

National Natural Science Foundation of China (82072477)

More Information
  • Received Date: June 14, 2024
  • Accepted Date: August 14, 2024
  • Available Online: February 26, 2025
  • The SEPN1 gene encodes selenoprotein N, and mutations in this gene can cause SEPN1-related myopathy (SEPN1-RM). SEPN1-RM is an extremely rare and complex congenital myopathy with an insidious onset and slow progression, often leading to multi-system involvement. The main clinical manifestations include axial and proximal muscle weakness, early respiratory dysfunction, and spinal deformities. This article reports the diagnosis and treatment conditions for a pediatric patient carrying novel mutation in SEPN1 gene who underwent spinal orthopedic fusion surgery. After detailed multidisciplinary evaluation, adequate preoperative preparation, and meticulous perioperative management, the patient successfully underwent high-risk spinal orthopedic surgery and recovered well. Based on the patient's diagnosis, perioperative management, and follow-up, combined with a review of the latest domestic and international literature, this article systematically discusses the diagnostic and therapeutic characteristics of this rare disease. The aim is to enhance clinicians' understanding of such diseases and to provide evidence-based support and reference for perioperative comprehensive management strategies for rare diseases.
  • Related Articles

    [1]LIU Shupeng, YU Mengyang, WU Xiaofei, WANG Hongyun. Clinical Landscape of Therapeutic Cancer Vaccines: Challenges and Opportunities[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1356-1363. DOI: 10.12290/xhyxzz.2024-0130
    [2]WEN Xuejun, ZHOU Wuhao, GUO Zhide, ZHANG Xianzhong. Integrin αvβ3 Targeted Radiopharmaceutical 99mTc-RGD Combined with Anti-PD-L1 mAb to Enhance the Anti-tumor Effect in Tumor Immunotherapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 766-773. DOI: 10.12290/xhyxzz.2023-0155
    [3]LI Tao, ZHANG Kan, YANG Wenyu, LIU Lu, ZHENG Xuan, ZHANG Fan, HU Yi. Clinical Application of Immune Checkpoint Inhibitors CTLA-4 in Solid Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 652-659. DOI: 10.12290/xhyxzz.2022-0617
    [4]WANG Shuo, DENG Yuntian, PENG Huan, ZHANG Xiangfeng. Progress in the Treatment of Non-small Cell Lung Cancer with Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 409-415. DOI: 10.12290/xhyxzz.2022-0151
    [5]LI Linrong, LI Yan, SUN Qiang. Clinical Trials and Current Progress in the Treatment of Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 177-183. DOI: 10.12290/xhyxzz.2022-0085
    [6]LUO Xiangchong, WANG Zhouqing, LI Qiongyan, MAO Guibing, AN Le, ZHU Jiahong, TAO E'hong, SUN Lifei, WANG Shengfei, LI Gaofeng. Pharmacological Effects and Clinical Evaluation of PD-1 Inhibitor of Tislelizumab in the Treatment of Advanced Malignant Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 679-686. DOI: 10.12290/xhyxzz.2021-0691
    [7]LUO Yanwen, ZHU Qingli. Application of Radiomics in Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 983-988. DOI: 10.12290/xhyxzz.2021-0011
    [8]HUA Yuwei, ZHAO Lin. Diagnosis and Management of Immunotherapy-related Liver Toxicity[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 798-806. DOI: 10.12290/xhyxzz.2021-0138
    [9]Mei GUAN, Chun-mei BAI. Medical Treatment for Biliary Tract Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 325-333. DOI: 10.3969/j.issn.1674-9081.20190247
    [10]Han-zhong LI, Yu-shi ZHANG, Guo-yang ZHENG. Commentary on and Expectation of Tumor Immunotherapy[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(4): 289-294. DOI: 10.3969/j.issn.1674-9081.2018.04.001
  • Cited by

    Periodical cited type(5)

    1. 姚晓倩,洪敏萍,蔡宏杰,吴慧青. 基于超声影像组学术前预测浸润性乳腺癌患者腋窝淋巴结状态. 现代实用医学. 2023(01): 116-119 .
    2. 林文华,杨少玲,赫兰,陶均佳,张红珍,顾家红,赵坤,胡静. 基于术前超声及钼靶特征的列线图预测乳腺癌腋窝淋巴结转移的价值. 中国临床医学影像杂志. 2023(09): 647-653 .
    3. 牛梓涵,朱庆莉,姜玉新. 超声在早期乳腺癌腋窝淋巴结转移诊断中的应用进展. 中华超声影像学杂志. 2023(10): 889-893 .
    4. 李玥,曹军英. 多模态超声在乳腺癌精准诊断中研究进展. 临床军医杂志. 2022(07): 661-665 .
    5. 赵萍,闫朝岐,杨学伟,李洋,叶倩. 乳腺癌腋窝淋巴结超声检查评价及研究进展. 中国临床研究. 2022(09): 1270-1272+1291 .

    Other cited types(5)

Catalog

    Article Metrics

    Article views PDF downloads Cited by(10)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close